Regina Berkovich MD, PhD Inc.

West Hollywood, California 90048

3 studies enrolling now · 11 studies all time

What they study most

Multiple Sclerosis, Multiple Sclerosis (MS) Primary Progressive, Multiple Sclerosis, Relapsing-Remitting, Relapse Remitting Multiple Sclerosis, Relapsing Forms of MS, Relapsing Multiple Sclerosis, Relapsing Multiple Sclerosis (RMS), Relapsing Remitting Multiple Sclerosis, Secondary Progressive Multiple Sclerosis, Secondary Progressive Multiple Sclerosis (SPMS)

Studies at this site

• A Study of Orelabrutinib in Patients With Secondary Progressive Multiple Sclerosis — Recruiting now
• A Study of Orelabrutinib in Patients With Primary Progressive Multiple Sclerosis — Recruiting now
• A Study to Evaluate the Efficacy and Safety of Remibrutinib in Secondary Progressive Multiple Sclerosis — Recruiting now
• Efficacy and Safety of Remibrutinib Compared to Teriflunomide in Participants With Relapsing Multiple Sclerosis (RMS) — Running, not enrolling
• Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of a New Maintenance Dosing Regimen of Ofatumumab — Running, not enrolling
• Study to Assess the Effect of Ofatumumab in Treatment Naïve, Very Early RRMS Patients Benchmarked Against Healthy Controls. — Completed
• A Study of Suboptimally Controlled Participants Previously Taking Oral or Infusion DMDs for RMS (MASTER-2) — Completed
• A Study of Obexelimab in Patients With Relapsing Multiple Sclerosis (MoonStone) — Running, not enrolling
• Observational Study of Persistence on Bafiertam Treatment in Routine Clinical Practice — Stopped early
• Study of Diroximel Fumarate in the Real-World Setting — Stopped early
• A Pilot Study to Characterize the Biological Effect of a Pre-planned 12 Week Dose Interruption of Natalizumab — Status unconfirmed